| Overview |
| bs-5487R-PE-Cy5 |
| MAPK8 (Thr183 + Tyr185) Antibody, PE-Cy5 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic phosphopeptide derived from human MAPK9 around the phosphorylation site of Thr183+Tyr185 |
| Thr183 + Tyr185 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5601 |
| Nucleus |
| MAPK8/MAPK9phospho T183/Y185; Mapk9; C Jun kinase 2; C Jun N terminal kinase 2; JNK 2; JNK-2; JNK 55; JNK2 alpha; JNK2 beta; JNK2alpha; JNK2B; JNK2beta; JNK55; Jun kinase; MAP kinase 9; MAPK 9; Mitogen activated protein kinase 9; P54 alpha; P54aSAPK; PRKM9; SAPK alpha; SAPK1a; SAPKa; Stress activated protein kinase JNK2. |
| phosphorylated at the Thr-Pro-Tyr phosphorylation motif instead of the characteristic MAP kinase Thr-Glu-Tyr motif. JNK2 (p54a, SAPK1a), along with JNK1 and JNK3, is thought to play an important role in nuclear signal transduction through its environmental stress activation and subsequent phosphorylation of the nuclear transcription factor p53. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz